The BioEscalator publishes its Portfolio 2025 – a guide for potential partners & investors

The BioEscalator, the University of Oxford’s biomedical incubator, is home to a stellar collection of companies using cutting-edge science to tackle profound medical challenges.

The new Portfolio 2025 brings them together to showcase their innovative approaches and provide a valuable guide for potential investors and partners.

The Portfolio 2025 includes:

A foreword from Tim Funnell, Partner at Monograph Capital
One-page profiles of tenants, from founders and funding to achievements and ambitions
A map of their partners and investors across the world
The alumni
BioEscalator achievement metrics

The Portfolio 2025 is a guide to the activities of BioEscalator tenants – you can make contact with them via the details given in their profiles, or via the BioEscalator team, if you would like to know more.

BioEscalator_partner_brands_Quadrangle_ForWhiteBackgrounds

← Previous Next →

Recent news

Oxford launches £118m AI-driven vaccine research programme with the Ellison Institute of Technology

Sep 2, 2025

The University of Oxford, in partnership with the Ellison Institute of Technology (EIT), has launched a major new £118m vaccine research programme. Led by the Oxford Vaccine Group, the initiative – CoI-AI (Correlates of Immunity-Artificial Intelligence) – will combine...

Warneford Park – Update on proposals

Aug 22, 2025

Warneford Park is the focus of a new initiative by Oxford Health NHS Foundation Trust and the University of Oxford, who have reached a significant milestone in their plans to create a world-leading mental health and medical research centre on the existing hospital...

Bicester Motion completes HQ for YASA

Aug 18, 2025

Bicester Motion has announced the practical completion of YASA’s new £26.8 million headquarters, delivered in partnership with Kier, marking the first phase of The Ranges development for innovative automotive and aviation companies. YASA, a University of Oxford...